PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsHypromellose
Hypromellose
Hypromellose is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
advanced eye relief/ redness maximum reliefC2002632024-09-25
alcon tears lubricant eye dropsC2002632023-12-14
artificial tearsOTC monograph final2019-10-28
auroviscC2002632024-11-27
aurovisc lubricant hypromellose 2208 (15000 mpa.s) gel/dropsC2002632025-02-04
aurovisc lubricant hypromellose 2208 (15000 mpa.s) solution/dropsOTC monograph final2023-01-11
aurovisc oeC2002632025-03-24
biomedic artificial tearsExport only2023-03-17
bion tearsC2002632023-12-14
clear eyes complete 7 symptom reliefOTC monograph final2010-08-15
Show 50 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
S: Sensory organ drugs
S01: Ophthalmologicals
S01K: Surgical aids, ophthalmologic
S01KA: Viscoelastic substances
S01KA02: Hypromellose
HCPCS
No data
Clinical
Clinical Trials
517 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CataractD002386EFO_0001059H26.911
Keratoconjunctivitis siccaD007638EFO_100090611
Dry eye syndromesD015352H04.1211
Eye diseasesD005128EFO_0003966H4411
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHypromellose
INNhypromellose
Description
Hypromellose (INN), short for hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer used in eye drops, as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2108956
ChEBI ID
PubChem CID
DrugBank
UNII ID0HO1H52958 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 11,035 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,874 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use